Emyria Ltd has released a press release.
Emyria Welcomes Tattarang as Strategic Investor
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Emyria
- MDMA Analogue Development Milestone
- Emyria selected to join Palantirs Foundry Builders Program
- Novel MDMA Analogue Screening Program Advanced
- Emyria Expands Psychiatry Advisory for Psychedelics and MDMA
- MDMA-analogues Show Promise for Parkinsons Disease
Later from Emyria
- Emyria receives $1,162,000 R&D Tax Incentive Refund
- Positive initial MDMA-analogue screening results
- Positive animal data for Emyrias ultra-pure CBD capsule
- Pause in Trading
- Emyria adds wearables to psychedelic-assisted therapy trials
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria